Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 259

1.

Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.

Marfo K, Ajaimy M, Colovai A, Kayler L, Greenstein S, Lubetzky M, Gupta A, Kamal L, de Boccardo G, Masiakos P, Kinkhabwala M, Akalin E.

Transplantation. 2014 Nov 27;98(10):1082-8. doi: 10.1097/TP.0000000000000191.

PMID:
24873780
2.

Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.

Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.

Transplantation. 2015 Jun;99(6):1156-64. doi: 10.1097/TP.0000000000000511.

PMID:
25629531
3.

Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.

Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.

Transplant Proc. 2012 Nov;44(9):2529-31. doi: 10.1016/j.transproceed.2012.09.102.

PMID:
23146444
4.

Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.

Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.

Clin Biochem. 2013 Oct;46(15):1389-93. doi: 10.1016/j.clinbiochem.2013.05.053. Epub 2013 May 29.

PMID:
23726814
5.

Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.

Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.

Nephrol Dial Transplant. 2012 Mar;27(3):1231-8. doi: 10.1093/ndt/gfr429. Epub 2011 Aug 2.

7.

Impact of Donor Specific HLA Antibody Monitoring After Kidney Transplantation.

Rao S, Ghanta M, Lee IJ, Gillespie A, Parekh HK, Geier SS, Zeng X, Karachristos A, Lau KN, Karhadkar S, Di Carlo A, Sifontis NM, Constantinescu S.

Clin Transpl. 2014:143-51.

PMID:
26281139
8.

Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.

Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J.

Transplant Proc. 2011 Jul-Aug;43(6):2154-6. doi: 10.1016/j.transproceed.2011.06.053.

PMID:
21839219
9.

Highly Sensitized Patients: Miami Transplant Institute Experience.

Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R.

Clin Transpl. 2014:171-8.

PMID:
26281142
10.

Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment.

Ishida H, Furusawa M, Shimizu T, Nozaki T, Tanabe K.

Transpl Int. 2014 Apr;27(4):371-82. doi: 10.1111/tri.12267.

11.

De novo donor specific antibodies and patient outcomes in renal transplantation.

DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.

Clin Transpl. 2011:351-8.

PMID:
22755430
12.

Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.

Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P.

Transplantation. 2016 Jan;100(1):159-66. doi: 10.1097/TP.0000000000000821.

PMID:
26262501
13.

C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.

Yell M, Muth BL, Kaufman DB, Djamali A, Ellis TM.

Transplantation. 2015 Jun;99(6):1151-5. doi: 10.1097/TP.0000000000000699.

PMID:
25839705
14.

Kidney paired donation in the presence of donor-specific antibodies.

Blumberg JM, Gritsch HA, Reed EF, Cecka JM, Lipshutz GS, Danovitch GM, McGuire S, Gjertson DW, Veale JL.

Kidney Int. 2013 Nov;84(5):1009-16. doi: 10.1038/ki.2013.206. Epub 2013 May 29.

15.

Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?

Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.

Transpl Immunol. 2013 Dec;29(1-4):28-33. doi: 10.1016/j.trim.2013.07.002. Epub 2013 Jul 29.

PMID:
23907088
16.
17.

Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.

Aubert V, Venetz JP, Pantaleo G, Pascual M.

Hum Immunol. 2009 Aug;70(8):580-3. doi: 10.1016/j.humimm.2009.04.011. Epub 2009 Apr 16.

PMID:
19375474
18.

Donor specific antibodies before and after kidney transplant: the University of Colorado Experience.

Cooper JE, Gralla J, Adebiyi O, Wiseman AC, Chan L.

Clin Transpl. 2013:407-12.

PMID:
25095536
19.

Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.

Cooper JE, Gralla J, Chan L, Wiseman AC.

Clin Transpl. 2011:359-64.

PMID:
22755431
20.

Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.

Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.

Transplantation. 2014 Mar 27;97(6):642-7. doi: 10.1097/01.TP.0000440954.14510.6a.

PMID:
24637863
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk